Clinical Trial Update: Determining the Effect of Abacavir on Platelet Activation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of abacavir on platelet activation in individuals with HIV infection and cardiovascular disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Drugs mentioned

• Ziagen (abacavir) (abacavir)

Snippet

Sponsor: Bayside Health | Conditions: HIV, Cardiovascular Disease | Phase 4 | Status: COMPLETED